Methods for treatment of patients with myelodysplastic syndromes
US-2024408250-A1 · Dec 12, 2024 · US
This page is not indexed by search engines while we improve data quality.
Actinium Pharmaceuticals Inc — Physics
Actinium Pharmaceuticals Inc holds 9 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Actinium Pharmaceuticals Inc |
| Technology | Physics |
| Patents in slice | 9 |
| Recent patents in slice | 3 |
| First year | 2017 |
| Last year | 2024 |
Representative patents
Notable publications linking Actinium Pharmaceuticals Inc to Physics.
Methods for treatment of patients with myelodysplastic syndromes
US-2024408250-A1 · Dec 12, 2024 · US
Methods for treatment of patients with myelodysplastic syndromes
US-12083192-B2 · Sep 10, 2024 · US
Methods for treatment of patients with myelodysplastic syndromes
US-12083192-B2 · Sep 10, 2024 · US
Radioimmunoconjugates targeting calreticulin for use in the treatment of cancer
US-2024226345-A1 · Jul 11, 2024 · US
Recent filings
Latest patents from Actinium Pharmaceuticals Inc in Physics.
Methods for treatment of patients with myelodysplastic syndromes
US-2024408250-A1 · Dec 12, 2024 · US
Methods for treatment of patients with myelodysplastic syndromes
US-2024408250-A1 · Dec 12, 2024 · US
Methods for treatment of patients with myelodysplastic syndromes
US-12083192-B2 · Sep 10, 2024 · US
Methods for treatment of patients with myelodysplastic syndromes
US-12083192-B2 · Sep 10, 2024 · US
Radioimmunoconjugates targeting calreticulin for use in the treatment of cancer
US-2024226345-A1 · Jul 11, 2024 · US
Related pages
Navigate to parent entity pages.